Media Summary: Dr. Nikolai Schwabe, CEO of ProImmune, explains the Join our Senior Immunology Sales Specialist, Dr. Emilee Knowlton in this webinar as she describes ProImmune's experience in ... A key feature of the immune system is the ability to distinguish self from nonself, or foreign. This remarkable ability is necessary ...

Propresent The Antigen Presentation Assay - Detailed Analysis & Overview

Dr. Nikolai Schwabe, CEO of ProImmune, explains the Join our Senior Immunology Sales Specialist, Dr. Emilee Knowlton in this webinar as she describes ProImmune's experience in ... A key feature of the immune system is the ability to distinguish self from nonself, or foreign. This remarkable ability is necessary ... antigenpresentation Here I explain how nucleated cells and professional Immunogenicity remains one of the most complex and critical challenges in drug design and development, requiring the strategic ... Lecture 15 from Biol 370 Immunology Fall 2023 (an undergraduate immunology course) from Dr. Brianne Barker.

Novel epitopes can be identified by the highly sensitive The ProScern® Dendritic Cell (DC)-T cell This video describes the origin, development, and function of Every day billions of tiny invaders called pathogens want to make our bodies their new homes. Luckily, we have a powerful army ... Dr. Emilee Knowlton takes you through our ProStorm® Cytokine Release Triparna Sen, PhD, The Ohio State University, Columbus, OH, discusses the role of

Integrated platforms can be used to mitigate immunogenicity risk and characterize immune responses during the drug design and ...

Photo Gallery

ProPresent® - The Antigen Presentation Assay
ProPresent Antigen Presentation Assay Webcast
Edmund Neo: Application of ProPresent® Antigen Presentation Assay to Assess Immunogenicity
Antigen Presentation: MHC Class I vs. MHC Class II
Antigen presentation via MHCI and MHCII explained!
Edmund Neo: Integrated Adaptive Immunogenicity Assessment for Biologics and Peptide Therapeutics
Immunology Fall 2023: Lecture 15 Antigen Presentation
Emilee Knowlton: Pro5® Pentamers and ProT2® Tetramers for tracking antigen-specific T cells
Emilee Knowlton: Epitope identification & clinical immune monitoring in gene therapy & IO programs
Antigen presentation kinetics control T cell/dendritic cell interactions and follicular...
Mike Zimmer: Engineering a less immunogenic bacterial protease for treatment of IgA Nephropathy
Emilee Knowlton: Epitope identification and clinical immune monitoring in immune oncology programs
View Detailed Profile
ProPresent® - The Antigen Presentation Assay

ProPresent® - The Antigen Presentation Assay

Dr. Nikolai Schwabe, CEO of ProImmune, explains the

ProPresent Antigen Presentation Assay Webcast

ProPresent Antigen Presentation Assay Webcast

Join our Senior Immunology Sales Specialist, Dr. Emilee Knowlton in this webinar as she describes ProImmune's experience in ...

Edmund Neo: Application of ProPresent® Antigen Presentation Assay to Assess Immunogenicity

Edmund Neo: Application of ProPresent® Antigen Presentation Assay to Assess Immunogenicity

ProPresent

Antigen Presentation: MHC Class I vs. MHC Class II

Antigen Presentation: MHC Class I vs. MHC Class II

A key feature of the immune system is the ability to distinguish self from nonself, or foreign. This remarkable ability is necessary ...

Antigen presentation via MHCI and MHCII explained!

Antigen presentation via MHCI and MHCII explained!

antigenpresentation #microbiology Here I explain how nucleated cells and professional

Edmund Neo: Integrated Adaptive Immunogenicity Assessment for Biologics and Peptide Therapeutics

Edmund Neo: Integrated Adaptive Immunogenicity Assessment for Biologics and Peptide Therapeutics

Immunogenicity remains one of the most complex and critical challenges in drug design and development, requiring the strategic ...

Immunology Fall 2023: Lecture 15 Antigen Presentation

Immunology Fall 2023: Lecture 15 Antigen Presentation

Lecture 15 from Biol 370 Immunology Fall 2023 (an undergraduate immunology course) from Dr. Brianne Barker.

Emilee Knowlton: Pro5® Pentamers and ProT2® Tetramers for tracking antigen-specific T cells

Emilee Knowlton: Pro5® Pentamers and ProT2® Tetramers for tracking antigen-specific T cells

Novel epitopes can be identified by the highly sensitive

Emilee Knowlton: Epitope identification & clinical immune monitoring in gene therapy & IO programs

Emilee Knowlton: Epitope identification & clinical immune monitoring in gene therapy & IO programs

Novel epitopes can be identified by the highly sensitive

Antigen presentation kinetics control T cell/dendritic cell interactions and follicular...

Antigen presentation kinetics control T cell/dendritic cell interactions and follicular...

Antigen presentation

Mike Zimmer: Engineering a less immunogenic bacterial protease for treatment of IgA Nephropathy

Mike Zimmer: Engineering a less immunogenic bacterial protease for treatment of IgA Nephropathy

Using ProImmune's

Emilee Knowlton: Epitope identification and clinical immune monitoring in immune oncology programs

Emilee Knowlton: Epitope identification and clinical immune monitoring in immune oncology programs

Novel epitopes can be identified by the highly sensitive

ProScern® DC-T cell Proliferation Assay

ProScern® DC-T cell Proliferation Assay

The ProScern® Dendritic Cell (DC)-T cell

Antigen Presenting Cells (APC)

Antigen Presenting Cells (APC)

This video describes the origin, development, and function of

Immune Response Explained: T-Cell Activation

Immune Response Explained: T-Cell Activation

Every day billions of tiny invaders called pathogens want to make our bodies their new homes. Luckily, we have a powerful army ...

ProStorm® Cytokine Release Assay: how does it work?

ProStorm® Cytokine Release Assay: how does it work?

Dr. Emilee Knowlton takes you through our ProStorm® Cytokine Release

Antigen presentation machinery suppression in small cell lung cancer

Antigen presentation machinery suppression in small cell lung cancer

Triparna Sen, PhD, The Ohio State University, Columbus, OH, discusses the role of

Emilee Knowlton: Epitope identification and clinical immune monitoring in IO programs

Emilee Knowlton: Epitope identification and clinical immune monitoring in IO programs

Novel epitopes can be identified by the highly sensitive

Jeremy Fry: An Integrated Approach to Managing Immunogenicity Risk and Optimum Protein Design

Jeremy Fry: An Integrated Approach to Managing Immunogenicity Risk and Optimum Protein Design

Integrated platforms can be used to mitigate immunogenicity risk and characterize immune responses during the drug design and ...